CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility; Terms Not Disclosed

CMC Biologics today announced the acquisition of XOMA Corporation's

, large-scale manufacturing operations and affiliated assets located in Berkeley, California. Financial terms of the transaction were not disclosed. "We are very pleased to expand our clinical and commercial manufacturing operations to one of largest and most robust biotechnology clusters in the world," said Claes Glassell, Chief Executive Officer of CMC Biologics. "Establishing a facility in the Bay Area complements our existing facilities located in Bothell, Washington and in Copenhagen Denmark, and supports our continued growth and addresses the growing demand of our customers for cGMP clinical and commercial production of biopharmaceuticals."